Warfarin showed a trend towards lower prevalence in the DAPT group than the no DAPT group.
← all excerpts
Antithrombotic therapy after femoropopliteal artery stenting: 12-month results from Japan Postmarketing Surveillance.
1
—
—
Warfarin showed a trend towards lower prevalence in the DAPT group than the no DAPT group.